APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oligonucleotides

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Selected research

Market Structure

Global Oligonucleotides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchOligonucleotides Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oligonucleotides Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oligonucleotides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oligonucleotides Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Oligonucleotides Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.

Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.

Read the full market overview

North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.

In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.

Report Includes

This report provides an overview of the global Oligonucleotides market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oligonucleotides and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oligonucleotides revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oligonucleotides market size, projected growth trends, production technologies, key applications, and end-use industries.

Oligonucleotides Segment by Company

Integrated DNA Technologies

Agilent

Sigma-aldrich

Eurofins Genomics

L.G.C Biosearch Technologies

Eurogentec S.A

Nitto Denko Avecia Inc

GenScript

BBI Life Sciences

GeneDesign

TriLink BioTechnologies

SGS DNA

LC Sciences

Twist Bioscience

Creative Biogene

General Biosystems

Oligonucleotides Segment by Type

DNA Oligos

RNA Oligos

Oligonucleotides Segment by Application

Pharmaceutical

Research

Diagnostic

Oligonucleotides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oligonucleotides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oligonucleotides industry.

Chapter 3: Detailed analysis of Oligonucleotides companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotidesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DNA Oligos Table 3. Key Players of RNA Oligos Table 4. Global Oligonucleotides Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Table 6. Key Players of Research Table 7. Key Players of Diagnostic Table 8. Global Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Oligonucleotides Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Oligonucleotides Market Share by Region (2021-2026) Table 11. Global Oligonucleotides Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Oligonucleotides Market Share by Region (2027-2032) Table 13. Oligonucleotides Industry Trends Table 14. Oligonucleotides Industry Drivers Table 15. Oligonucleotides Industry Opportunities and Challenges Table 16. Oligonucleotides Industry Restraints Table 17. Global Oligonucleotides Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Oligonucleotides Revenue Market Share by Company (2021-2026) Table 19. Global Oligonucleotides Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Oligonucleotides Key Company Head Office and Area Served Table 21. Global Oligonucleotides Company, Product Type & Application Table 22. Global Oligonucleotides Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Oligonucleotides Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Oligonucleotides Revenue Market Share by Type (2021-2026) Table 29. Global Oligonucleotides Revenue Market Share by Type (2027-2032) Table 30. Global Oligonucleotides Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Oligonucleotides Revenue Market Share by Application (2021-2026) Table 34. Global Oligonucleotides Revenue Market Share by Application (2027-2032) Table 35. Integrated DNA Technologies Company Information Table 36. Integrated DNA Technologies Business Overview Table 37. Integrated DNA Technologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Integrated DNA Technologies Oligonucleotides Product Portfolio Table 39. Integrated DNA Technologies Recent Development Table 40. Agilent Company Information Table 41. Agilent Business Overview Table 42. Agilent Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Agilent Oligonucleotides Product Portfolio Table 44. Agilent Recent Development Table 45. Sigma-aldrich Company Information Table 46. Sigma-aldrich Business Overview Table 47. Sigma-aldrich Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sigma-aldrich Oligonucleotides Product Portfolio Table 49. Sigma-aldrich Recent Development Table 50. Eurofins Genomics Company Information Table 51. Eurofins Genomics Business Overview Table 52. Eurofins Genomics Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Eurofins Genomics Oligonucleotides Product Portfolio Table 54. Eurofins Genomics Recent Development Table 55. L.G.C Biosearch Technologies Company Information Table 56. L.G.C Biosearch Technologies Business Overview Table 57. L.G.C Biosearch Technologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. L.G.C Biosearch Technologies Oligonucleotides Product Portfolio Table 59. L.G.C Biosearch Technologies Recent Development Table 60. Eurogentec S.A Company Information Table 61. Eurogentec S.A Business Overview Table 62. Eurogentec S.A Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eurogentec S.A Oligonucleotides Product Portfolio Table 64. Eurogentec S.A Recent Development Table 65. Nitto Denko Avecia Inc Company Information Table 66. Nitto Denko Avecia Inc Business Overview Table 67. Nitto Denko Avecia Inc Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Nitto Denko Avecia Inc Oligonucleotides Product Portfolio Table 69. Nitto Denko Avecia Inc Recent Development Table 70. GenScript Company Information Table 71. GenScript Business Overview Table 72. GenScript Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GenScript Oligonucleotides Product Portfolio Table 74. GenScript Recent Development Table 75. BBI Life Sciences Company Information Table 76. BBI Life Sciences Business Overview Table 77. BBI Life Sciences Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BBI Life Sciences Oligonucleotides Product Portfolio Table 79. BBI Life Sciences Recent Development Table 80. GeneDesign Company Information Table 81. GeneDesign Business Overview Table 82. GeneDesign Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GeneDesign Oligonucleotides Product Portfolio Table 84. GeneDesign Recent Development Table 85. TriLink BioTechnologies Company Information Table 86. TriLink BioTechnologies Business Overview Table 87. TriLink BioTechnologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. TriLink BioTechnologies Oligonucleotides Product Portfolio Table 89. TriLink BioTechnologies Recent Development Table 90. SGS DNA Company Information Table 91. SGS DNA Business Overview Table 92. SGS DNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. SGS DNA Oligonucleotides Product Portfolio Table 94. SGS DNA Recent Development Table 95. LC Sciences Company Information Table 96. LC Sciences Business Overview Table 97. LC Sciences Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. LC Sciences Oligonucleotides Product Portfolio Table 99. LC Sciences Recent Development Table 100. Twist Bioscience Company Information Table 101. Twist Bioscience Business Overview Table 102. Twist Bioscience Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Twist Bioscience Oligonucleotides Product Portfolio Table 104. Twist Bioscience Recent Development Table 105. Creative Biogene Company Information Table 106. Creative Biogene Business Overview Table 107. Creative Biogene Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Creative Biogene Oligonucleotides Product Portfolio Table 109. Creative Biogene Recent Development Table 110. General Biosystems Company Information Table 111. General Biosystems Business Overview Table 112. General Biosystems Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. General Biosystems Oligonucleotides Product Portfolio Table 114. General Biosystems Recent Development Table 115. North America Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Oligonucleotides Market Size by Country (2021-2026) Table 121. North America Oligonucleotides Market Size by Country (2027-2032) Table 122. Europe Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Oligonucleotides Market Size by Country (2021-2026) Table 128. Europe Oligonucleotides Market Size by Country (2027-2032) Table 129. China Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 130. China Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 131. China Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 132. China Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Oligonucleotides Market Size by Country (2021-2026) Table 139. Asia Oligonucleotides Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Oligonucleotides Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Oligonucleotides Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Oligonucleotides Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Oligonucleotides Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Oligonucleotides Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Oligonucleotides Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Oligonucleotides Product Image Figure 2. Global Oligonucleotides Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oligonucleotides Market Share by Type: 2025 VS 2032 Figure 4. DNA Oligos Image Figure 5. RNA Oligos Image Figure 6. Global Oligonucleotides Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Oligonucleotides Market Share by Application: 2025 VS 2032 Figure 8. Pharmaceutical Image Figure 9. Research Image Figure 10. Diagnostic Image Figure 11. Global Oligonucleotides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 13. Global Oligonucleotides Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Oligonucleotides Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Oligonucleotides Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Oligonucleotides Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oligonucleotides Revenue Market Share by Type (2021-2032) Figure 20. Global Oligonucleotides Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oligonucleotides Revenue Market Share by Application (2021-2032) Figure 22. North America Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 23. North America Oligonucleotides Market Share by Type (2021-2032) Figure 24. North America Oligonucleotides Market Share by Application (2021-2032) Figure 25. North America Oligonucleotides Market Share by Country (2021-2032) Figure 26. United States Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 27. Canada Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 29. Europe Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 30. Europe Oligonucleotides Market Share by Type (2021-2032) Figure 31. Europe Oligonucleotides Market Share by Application (2021-2032) Figure 32. Europe Oligonucleotides Market Share by Country (2021-2032) Figure 33. Germany Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 34. France Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 36. Italy Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 37. Russia Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 39. China Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 40. China Oligonucleotides Market Share by Type (2021-2032) Figure 41. China Oligonucleotides Market Share by Application (2021-2032) Figure 42. Asia Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 43. Asia Oligonucleotides Market Share by Type (2021-2032) Figure 44. Asia Oligonucleotides Market Share by Application (2021-2032) Figure 45. Asia Oligonucleotides Market Share by Country (2021-2032) Figure 46. Japan Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 50. India Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 51. Australia Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Oligonucleotides Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Oligonucleotides Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Oligonucleotides Market Share by Country (2021-2032) Figure 56. Brazil Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 61. UAE Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 63. Chile Oligonucleotides Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Oligos
  • RNA Oligos
Applications
  • Pharmaceutical
  • Research
  • Diagnostic
Companies covered
  • Integrated DNA Technologies
  • Agilent
  • Sigma-aldrich
  • Eurofins Genomics
  • L.G.C Biosearch Technologies
  • Eurogentec S.A
  • Nitto Denko Avecia Inc
  • GenScript
  • BBI Life Sciences
  • GeneDesign
  • TriLink BioTechnologies
  • SGS DNA
  • LC Sciences
  • Twist Bioscience
  • Creative Biogene
  • General Biosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Oligos
  5. 1.2.3 RNA Oligos
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Oligonucleotides Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Research
  10. 1.3.4 Diagnostic
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Oligonucleotides Growth Trends by Region
  13. 1.5.1 Global Oligonucleotides Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Oligonucleotides Market Size by Region (2021-2026)
  15. 1.5.3 Oligonucleotides Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Oligonucleotides Market Dynamics
  1. 2.1 Oligonucleotides Industry Trends
  2. 2.2 Oligonucleotides Industry Drivers
  3. 2.3 Oligonucleotides Industry Opportunities and Challenges
  4. 2.4 Oligonucleotides Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oligonucleotides Revenue by Company (2021-2026)
  2. 3.2 Global Oligonucleotides Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oligonucleotides Key Company Head office and Area Served
  4. 3.4 Global Oligonucleotides Company, Product Type & Application
  5. 3.5 Global Oligonucleotides Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oligonucleotides Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oligonucleotides Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oligonucleotides Tier 1, Tier 2, and Tier 3
4 Oligonucleotides Market by Type
  1. 4.1 Global Oligonucleotides Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oligonucleotides Market Size by Type (2021-2032)
  3. 4.3 Global Oligonucleotides Market Size Share by Type (2021-2032)
5 Oligonucleotides Market by Application
  1. 5.1 Global Oligonucleotides Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oligonucleotides Market Size by Application (2021-2032)
  3. 5.3 Global Oligonucleotides Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Integrated DNA Technologies
  2. 6.1.1 Integrated DNA Technologies Company Information
  3. 6.1.2 Integrated DNA Technologies Business Overview
  4. 6.1.3 Integrated DNA Technologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Integrated DNA Technologies Oligonucleotides Product Portfolio
  6. 6.1.5 Integrated DNA Technologies Recent Developments
  7. 6.2 Agilent
  8. 6.2.1 Agilent Company Information
  9. 6.2.2 Agilent Business Overview
  10. 6.2.3 Agilent Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Agilent Oligonucleotides Product Portfolio
  12. 6.2.5 Agilent Recent Developments
  13. 6.3 Sigma-aldrich
  14. 6.3.1 Sigma-aldrich Company Information
  15. 6.3.2 Sigma-aldrich Business Overview
  16. 6.3.3 Sigma-aldrich Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sigma-aldrich Oligonucleotides Product Portfolio
  18. 6.3.5 Sigma-aldrich Recent Developments
  19. 6.4 Eurofins Genomics
  20. 6.4.1 Eurofins Genomics Company Information
  21. 6.4.2 Eurofins Genomics Business Overview
  22. 6.4.3 Eurofins Genomics Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Genomics Oligonucleotides Product Portfolio
  24. 6.4.5 Eurofins Genomics Recent Developments
  25. 6.5 L.G.C Biosearch Technologies
  26. 6.5.1 L.G.C Biosearch Technologies Company Information
  27. 6.5.2 L.G.C Biosearch Technologies Business Overview
  28. 6.5.3 L.G.C Biosearch Technologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 L.G.C Biosearch Technologies Oligonucleotides Product Portfolio
  30. 6.5.5 L.G.C Biosearch Technologies Recent Developments
  31. 6.6 Eurogentec S.A
  32. 6.6.1 Eurogentec S.A Company Information
  33. 6.6.2 Eurogentec S.A Business Overview
  34. 6.6.3 Eurogentec S.A Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eurogentec S.A Oligonucleotides Product Portfolio
  36. 6.6.5 Eurogentec S.A Recent Developments
  37. 6.7 Nitto Denko Avecia Inc
  38. 6.7.1 Nitto Denko Avecia Inc Company Information
  39. 6.7.2 Nitto Denko Avecia Inc Business Overview
  40. 6.7.3 Nitto Denko Avecia Inc Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nitto Denko Avecia Inc Oligonucleotides Product Portfolio
  42. 6.7.5 Nitto Denko Avecia Inc Recent Developments
  43. 6.8 GenScript
  44. 6.8.1 GenScript Company Information
  45. 6.8.2 GenScript Business Overview
  46. 6.8.3 GenScript Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GenScript Oligonucleotides Product Portfolio
  48. 6.8.5 GenScript Recent Developments
  49. 6.9 BBI Life Sciences
  50. 6.9.1 BBI Life Sciences Company Information
  51. 6.9.2 BBI Life Sciences Business Overview
  52. 6.9.3 BBI Life Sciences Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BBI Life Sciences Oligonucleotides Product Portfolio
  54. 6.9.5 BBI Life Sciences Recent Developments
  55. 6.10 GeneDesign
  56. 6.10.1 GeneDesign Company Information
  57. 6.10.2 GeneDesign Business Overview
  58. 6.10.3 GeneDesign Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GeneDesign Oligonucleotides Product Portfolio
  60. 6.10.5 GeneDesign Recent Developments
  61. 6.11 TriLink BioTechnologies
  62. 6.11.1 TriLink BioTechnologies Company Information
  63. 6.11.2 TriLink BioTechnologies Business Overview
  64. 6.11.3 TriLink BioTechnologies Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 TriLink BioTechnologies Oligonucleotides Product Portfolio
  66. 6.11.5 TriLink BioTechnologies Recent Developments
  67. 6.12 SGS DNA
  68. 6.12.1 SGS DNA Company Information
  69. 6.12.2 SGS DNA Business Overview
  70. 6.12.3 SGS DNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SGS DNA Oligonucleotides Product Portfolio
  72. 6.12.5 SGS DNA Recent Developments
  73. 6.13 LC Sciences
  74. 6.13.1 LC Sciences Company Information
  75. 6.13.2 LC Sciences Business Overview
  76. 6.13.3 LC Sciences Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 LC Sciences Oligonucleotides Product Portfolio
  78. 6.13.5 LC Sciences Recent Developments
  79. 6.14 Twist Bioscience
  80. 6.14.1 Twist Bioscience Company Information
  81. 6.14.2 Twist Bioscience Business Overview
  82. 6.14.3 Twist Bioscience Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Twist Bioscience Oligonucleotides Product Portfolio
  84. 6.14.5 Twist Bioscience Recent Developments
  85. 6.15 Creative Biogene
  86. 6.15.1 Creative Biogene Company Information
  87. 6.15.2 Creative Biogene Business Overview
  88. 6.15.3 Creative Biogene Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Creative Biogene Oligonucleotides Product Portfolio
  90. 6.15.5 Creative Biogene Recent Developments
  91. 6.16 General Biosystems
  92. 6.16.1 General Biosystems Company Information
  93. 6.16.2 General Biosystems Business Overview
  94. 6.16.3 General Biosystems Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 General Biosystems Oligonucleotides Product Portfolio
  96. 6.16.5 General Biosystems Recent Developments
7 North America
  1. 7.1 North America Oligonucleotides Market Size (2021-2032)
  2. 7.2 North America Oligonucleotides Market Size by Type
  3. 7.2.1 North America Oligonucleotides Market Size by Type (2021-2026)
  4. 7.2.2 North America Oligonucleotides Market Size by Type (2027-2032)
  5. 7.2.3 North America Oligonucleotides Market Share by Type (2021-2032)
  6. 7.3 North America Oligonucleotides Market Size by Application
  7. 7.3.1 North America Oligonucleotides Market Size by Application (2021-2026)
  8. 7.3.2 North America Oligonucleotides Market Size by Application (2027-2032)
  9. 7.3.3 North America Oligonucleotides Market Share by Application (2021-2032)
  10. 7.4 North America Oligonucleotides Market Size by Country
  11. 7.4.1 North America Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oligonucleotides Market Size by Country (2021-2026)
  13. 7.4.3 North America Oligonucleotides Market Size by Country (2027-2032)
  14. 7.4.4 North America Oligonucleotides Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oligonucleotides Market Size (2021-2032)
  2. 8.2 Europe Oligonucleotides Market Size by Type
  3. 8.2.1 Europe Oligonucleotides Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oligonucleotides Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oligonucleotides Market Share by Type (2021-2032)
  6. 8.3 Europe Oligonucleotides Market Size by Application
  7. 8.3.1 Europe Oligonucleotides Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oligonucleotides Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oligonucleotides Market Share by Application (2021-2032)
  10. 8.4 Europe Oligonucleotides Market Size by Country
  11. 8.4.1 Europe Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oligonucleotides Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oligonucleotides Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oligonucleotides Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oligonucleotides Market Size (2021-2032)
  2. 9.2 China Oligonucleotides Market Size by Type
  3. 9.2.1 China Oligonucleotides Market Size by Type (2021-2026)
  4. 9.2.2 China Oligonucleotides Market Size by Type (2027-2032)
  5. 9.2.3 China Oligonucleotides Market Share by Type (2021-2032)
  6. 9.3 China Oligonucleotides Market Size by Application
  7. 9.3.1 China Oligonucleotides Market Size by Application (2021-2026)
  8. 9.3.2 China Oligonucleotides Market Size by Application (2027-2032)
  9. 9.3.3 China Oligonucleotides Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oligonucleotides Market Size (2021-2032)
  2. 10.2 Asia Oligonucleotides Market Size by Type
  3. 10.2.1 Asia Oligonucleotides Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oligonucleotides Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oligonucleotides Market Share by Type (2021-2032)
  6. 10.3 Asia Oligonucleotides Market Size by Application
  7. 10.3.1 Asia Oligonucleotides Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oligonucleotides Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oligonucleotides Market Share by Application (2021-2032)
  10. 10.4 Asia Oligonucleotides Market Size by Country
  11. 10.4.1 Asia Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oligonucleotides Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oligonucleotides Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oligonucleotides Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oligonucleotides Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oligonucleotides Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oligonucleotides Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oligonucleotides Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oligonucleotides Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oligonucleotides Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oligonucleotides Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oligonucleotides Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oligonucleotides Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oligonucleotides Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oligonucleotides Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oligonucleotides Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oligonucleotides Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst